HIV is increasingly understood as a chronic condition, like diabetes or hypertension. Indeed, it can be, but only for those that are willing and able to make a commitment to take antiretroviral (ARV) medicines every day for the rest of their life. Data suggest that physicians cannot reliably assess adherence, and that patients often get insufficient help with adherence problems from physicians. The long-term goal of this project is to improve adherence to prescribed ARV medication regimens, and thereby health outcomes, of persons with HIV. To achieve these goals the study team will enroll 150 patients with HIV who are taking ARV medications in a randomized, crossover, intervention trial. The proposed project will use both electronic drug exposure monitoring (EDM) and detailed patient interviews to collect information about rates of, and barriers to, ARV medication adherence. In the intervention phase of the study, these data will be fed back to physicians, in the form of a report, before outpatient visits. Primary outcome measures for the intervention study will be changes in adherence as assessed by EDM, and changes in viral loads. To insure a diverse patient population and thus maximize the generalizability of our findings, the study sites are an HIV clinic at an academic medical center, a general medicine clinic at an academic medical center, a community health center, and a private practice. The proposed project will also 1) attempt to improve self-report of medication adherence by determining which self-report items best predict adherence, using BDM as a criterion, 2) examine the relationship of 4 measures of interpersonal care and 11 measures of primary care performance to medication adherence, and 3) describe employment-related barriers adherence, including ARV medication side effects, and determine how strongly these barriers affect adherence. This project is unique because it attempts to better understand and improve physician-patient communication around medication adherence for a prevalent, expensive, and treatable chronic condition.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA015679-02
Application #
6622573
Study Section
Special Emphasis Panel (ZRG1-AARR-8 (05))
Program Officer
Lambert, Elizabeth
Project Start
2002-04-01
Project End
2006-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
2
Fiscal Year
2003
Total Cost
$721,895
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Genberg, Becky L; Lee, Yoojin; Rogers, William H et al. (2015) Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav 19:85-92
Erlen, Judith A; Tamres, Lisa K; Reynolds, Nancy et al. (2015) Assessing usual care in clinical trials. West J Nurs Res 37:288-98
Petersen, Maya L; LeDell, Erin; Schwab, Joshua et al. (2015) Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr 69:109-18
Simoni, Jane M; Huh, David; Wang, Yan et al. (2014) The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav 18:2285-90
Genberg, Becky L; Lee, Yoojin; Rogers, William H et al. (2013) Stages of change for adherence to antiretroviral medications. AIDS Patient Care STDS 27:567-72
Rosen, M I; Black, A C; Arnsten, J H et al. (2013) Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav 17:142-7
Wilson, Ira B; Bangsberg, David R; Shen, Jie et al. (2013) Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr 64:448-54
Liu, Honghu; Wilson, Ira B; Goggin, Kathy et al. (2013) MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav 17:127-41
Simoni, Jane M; Huh, David; Wilson, Ira B et al. (2012) Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr 60:466-72
Genberg, Becky L; Wilson, Ira B; Bangsberg, David R et al. (2012) Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS 26:1415-23

Showing the most recent 10 out of 17 publications